FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2410282912> ?p ?o ?g. }

• W2410282912 abstract "Background The effect of antiphospholipid antibodies (aPL) on organ damage in Systemic Lupus Erythematosus (SLE) patients remains unclear as there is a limited number of studies with contrasting conclusions. Objectives The aim of this study was to assess the relative contribution of aPL to organ damage in SLE patients. Methods SLE patients (based on American College of Rheumatology [ACR] Classification Criteria) with less than 10 years of disease duration at registry entry were identified from the SLE registry of two centers. Clinical information retrieved included: demographics, disease duration, organ damage assessed by the Systemic Lupus International Collaborating Clinics/ACR Damage Index (SDI), and aPL profile. A “clinically significant” aPL profile was defined as: positive lupus anticoagulant test, anticardiolipin antibody IgG/M >40 GPL or MPL, and/or anti-β 2 Glycoprotein-I IgG/M > the 99th percentile), on two or more occasions, at least 12 weeks apart, within ±1 year of registry entry. The outcome variables were any increase of SDI at 5, 10 and/or 15 years of follow-up (time 0 was defined as registry entry). For univariate analysis the demographic and clinical characteristics of patients with and without a SDI increase at 5, 10 and 15 years were compared (Chi square or Fisher9s exact test for categorical data, Student t test or Mann-Whitney-Wilcoxon for continuous data as appropriate). The Generalized Estimated Equations (GEE) model was used as multivariate analysis to detect significant factors for increased SDI at 5, 10 and/or 15 years. Results We identified 262 patients with less than 10 years of disease duration, at least 5 years of prospective follow-up and a complete aPL profile (76% Caucasian, 8% African-American, 6% Asian, and 86% female). Mean age at diagnosis was 31 years (±12) and mean age at registry entry was 33 years (±12) with a mean disease duration of 1 year (±2). Eighty-eight (33%) patients had a clinically significant aPL profile. Twenty-one percent, 42%, and 57% of patients had new organ damage in 5, 10, and 15 years, respectively (Table I). On the univariate analysis: a) a significant aPL profile (p:0.02) and a older age at diagnosis (p:0.04) were significantly associated to any increase of SDI at 5 years; b) a shorter disease duration was significantly associated to any increase of SDI at 10 years (p:0.003) and 15 years (p:0.008); and c) male gender showed a tendency for any increase of SDI at 15 years without reaching significance (p:0.054). The GEE model showed that patients with a significant aPL profile (p:0.006,Odds Ratio, [OR]:1.9, 95% Confidence Interval,[CI]:1.2-3.1), older age at diagnosis (p:0.007, OR: 1.02, 95%CI 0.006-0.04) or male sex (p:0.017,OR: 1.9,95%CI 1.1-3.3) were more likely to experience an increase of SDI during the follow-up (Table II). Conclusions Our data demonstrate that: a) one-third of SLE patients have clinically significant aPL profiles; b) 21%, 42% and 57% of SLE patients have new organ damage in 5, 10 and 15 years; c) clinically significant aPL-profiles, older age at diagnosis, and male sex are associated with an increased risk of organ damage accrual during a fifteen year follow-up. Disclosure of Interest None declared" @default.
• W2410282912 created "2016-06-24" @default.
• W2410282912 creator A5003778731 @default.
• W2410282912 creator A5019135832 @default.
• W2410282912 creator A5021292232 @default.
• W2410282912 creator A5051174165 @default.
• W2410282912 creator A5062202714 @default.
• W2410282912 creator A5063535210 @default.
• W2410282912 creator A5064997405 @default.
• W2410282912 creator A5079447134 @default.
• W2410282912 creator A5079883376 @default.
• W2410282912 date "2015-06-01" @default.
• W2410282912 modified "2023-09-26" @default.
• W2410282912 title "FRI0408 Antiphospholipid Antibodies and the Risk of Damage Accrual in Systemic Lupus Erythematosus" @default.
• W2410282912 doi "https://doi.org/10.1136/annrheumdis-2015-eular.2034" @default.
• W2410282912 hasPublicationYear "2015" @default.
• W2410282912 type Work @default.
• W2410282912 sameAs 2410282912 @default.
• W2410282912 citedByCount "1" @default.
• W2410282912 countsByYear W24102829122023 @default.
• W2410282912 crossrefType "journal-article" @default.
• W2410282912 hasAuthorship W2410282912A5003778731 @default.
• W2410282912 hasAuthorship W2410282912A5019135832 @default.
• W2410282912 hasAuthorship W2410282912A5021292232 @default.
• W2410282912 hasAuthorship W2410282912A5051174165 @default.
• W2410282912 hasAuthorship W2410282912A5062202714 @default.
• W2410282912 hasAuthorship W2410282912A5063535210 @default.
• W2410282912 hasAuthorship W2410282912A5064997405 @default.
• W2410282912 hasAuthorship W2410282912A5079447134 @default.
• W2410282912 hasAuthorship W2410282912A5079883376 @default.
• W2410282912 hasConcept C126322002 @default.
• W2410282912 hasConcept C144301174 @default.
• W2410282912 hasConcept C159654299 @default.
• W2410282912 hasConcept C191093355 @default.
• W2410282912 hasConcept C198451711 @default.
• W2410282912 hasConcept C203014093 @default.
• W2410282912 hasConcept C2775915377 @default.
• W2410282912 hasConcept C2776670291 @default.
• W2410282912 hasConcept C2776874634 @default.
• W2410282912 hasConcept C2776912625 @default.
• W2410282912 hasConcept C2779075594 @default.
• W2410282912 hasConcept C2779134260 @default.
• W2410282912 hasConcept C2780022809 @default.
• W2410282912 hasConcept C2780868729 @default.
• W2410282912 hasConcept C38180746 @default.
• W2410282912 hasConcept C71924100 @default.
• W2410282912 hasConceptScore W2410282912C126322002 @default.
• W2410282912 hasConceptScore W2410282912C144301174 @default.
• W2410282912 hasConceptScore W2410282912C159654299 @default.
• W2410282912 hasConceptScore W2410282912C191093355 @default.
• W2410282912 hasConceptScore W2410282912C198451711 @default.
• W2410282912 hasConceptScore W2410282912C203014093 @default.
• W2410282912 hasConceptScore W2410282912C2775915377 @default.
• W2410282912 hasConceptScore W2410282912C2776670291 @default.
• W2410282912 hasConceptScore W2410282912C2776874634 @default.
• W2410282912 hasConceptScore W2410282912C2776912625 @default.
• W2410282912 hasConceptScore W2410282912C2779075594 @default.
• W2410282912 hasConceptScore W2410282912C2779134260 @default.
• W2410282912 hasConceptScore W2410282912C2780022809 @default.
• W2410282912 hasConceptScore W2410282912C2780868729 @default.
• W2410282912 hasConceptScore W2410282912C38180746 @default.
• W2410282912 hasConceptScore W2410282912C71924100 @default.
• W2410282912 hasLocation W24102829121 @default.
• W2410282912 hasOpenAccess W2410282912 @default.
• W2410282912 hasPrimaryLocation W24102829121 @default.
• W2410282912 hasRelatedWork W2087893230 @default.
• W2410282912 hasRelatedWork W2158263012 @default.
• W2410282912 hasRelatedWork W2171096642 @default.
• W2410282912 hasRelatedWork W2332732199 @default.
• W2410282912 hasRelatedWork W2337031373 @default.
• W2410282912 hasRelatedWork W2417370069 @default.
• W2410282912 hasRelatedWork W2505882164 @default.
• W2410282912 hasRelatedWork W2556891587 @default.
• W2410282912 hasRelatedWork W2610360197 @default.
• W2410282912 hasRelatedWork W2745074989 @default.
• W2410282912 hasRelatedWork W2754766086 @default.
• W2410282912 hasRelatedWork W2899267246 @default.
• W2410282912 hasRelatedWork W2901300444 @default.
• W2410282912 hasRelatedWork W2908241962 @default.
• W2410282912 hasRelatedWork W2909770510 @default.
• W2410282912 hasRelatedWork W2938268041 @default.
• W2410282912 hasRelatedWork W2968507135 @default.
• W2410282912 hasRelatedWork W3032950268 @default.
• W2410282912 hasRelatedWork W3035021685 @default.
• W2410282912 hasRelatedWork W3084889460 @default.
• W2410282912 isParatext "false" @default.
• W2410282912 isRetracted "false" @default.
• W2410282912 magId "2410282912" @default.
• W2410282912 workType "article" @default.